Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSTL | AMGN | GILD | BMY | VRTX |
| Company | Castle Biosciences Inc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 26.82 | 262.18 | 92.62 | 56.93 | 403.14 |
| High | 28.12 | 263.58 | 92.83 | 57.12 | 409.60 |
| Low | 26.82 | 261.25 | 92.03 | 56.73 | 402.72 |
| Last | 28.06 | 262.97 | 92.32 | 57.30 | 407.28 |
| Change | +1.41 | +2.33 | -0.05 | +0.74 | +4.58 |
| % Change | +5.29% | +0.89% | -0.05% | +1.31% | +1.14% |
| Volume | 59,111 | 289,775 | 292,582 | 916,124 | 120,067 |
| 20-Day Average Volume | 275,607 | 3,652,594 | 6,635,467 | 10,845,036 | 1,828,511 |
| Previous Close | 26.65 | 260.64 | 92.37 | 56.56 | 402.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 28.58 | 267.49 | 92.42 | 57.33 | 437.39 |
| 20-Day Raw Stochastic | 30.68% | 36.85% | 58.91% | 38.24% | 31.48% |
| 20-Day Relative Strength | 44.89% | 35.20% | 52.88% | 50.32% | 36.82% |
| Weighted Alpha | +29.89 | -17.88 | +20.51 | +16.22 | -8.96 |
| Today's Opinion | 8% Buy | 88% Sell | 88% Buy | 72% Buy | 72% Sell |
| Previous Opinion | 8% Sell | 88% Sell | 88% Buy | 56% Buy | 72% Sell |
| Last Month's Opinion | 72% Buy | 72% Sell | 100% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.65% since 12/24/24 | -0.51% since 12/24/24 | -1.66% since 12/24/24 | -1.58% since 12/24/24 | +0.17% since 12/24/24 |
| Low | 25.82 on 12/30/24 | 258.50 on 12/30/24 | 91.72 on 12/30/24 | 55.93 on 12/31/24 | 399.06 on 12/30/24 |
| High | 28.11 on 01/02/25 | 264.73 on 12/26/24 | 94.55 on 12/26/24 | 58.38 on 12/27/24 | 411.29 on 12/26/24 |
| 1-Month | |||||
| %Chg | -11.15% since 12/02/24 | -5.38% since 12/02/24 | -1.73% since 12/02/24 | -5.16% since 12/02/24 | -12.20% since 12/02/24 |
| Low | 25.82 on 12/30/24 | 253.30 on 12/19/24 | 89.15 on 12/13/24 | 55.04 on 12/13/24 | 377.85 on 12/19/24 |
| High | 32.60 on 12/06/24 | 281.38 on 12/03/24 | 94.65 on 12/11/24 | 60.09 on 12/03/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -2.00% since 10/02/24 | -17.70% since 10/02/24 | +9.03% since 10/02/24 | +5.74% since 10/02/24 | -11.52% since 10/02/24 |
| Low | 25.82 on 12/30/24 | 253.30 on 12/19/24 | 83.98 on 10/04/24 | 51.31 on 10/15/24 | 377.85 on 12/19/24 |
| High | 35.84 on 11/05/24 | 329.17 on 10/11/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | +31.23% since 07/02/24 | -15.33% since 07/02/24 | +35.07% since 07/02/24 | +40.53% since 07/02/24 | -13.70% since 07/02/24 |
| Low | 16.97 on 07/05/24 | 253.30 on 12/19/24 | 66.01 on 07/05/24 | 39.35 on 07/05/24 | 377.85 on 12/19/24 |
| High | 35.84 on 11/05/24 | 346.85 on 07/25/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 746,386 | 140,102,608 | 115,117,592 | 114,713,688 | 103,706,928 |
| Shares Outstanding, K | 28,007 | 537,533 | 1,246,266 | 2,028,177 | 257,529 |
| Annual Sales | 219,790,000 | 28,190,000,000 | 27,116,000,000 | 45,006,000,000 | 9,869,200,000 |
| Annual Net Income | -57,470,000 | 6,717,000,000 | 5,665,000,000 | 8,025,000,000 | 3,619,600,000 |
| Last Quarter Sales | 85,780,000 | 8,503,000,000 | 7,545,000,000 | 11,892,000,000 | 2,771,900,000 |
| Last Quarter Net Income | 2,270,000 | 2,830,000,000 | 1,253,000,000 | 1,211,000,000 | 1,045,400,000 |
| 60-Month Beta | 0.92 | 0.55 | 0.18 | 0.45 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.08 on 11/04/24 | 5.58 on 10/30/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 11/04/24 | 02/04/25 | 02/11/25 | 02/06/25 | 02/03/25 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.770 on 12/13/24 | 0.620 on 01/03/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/14/25 | 12/13/24 | 01/03/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 133.30 | 13.49 | 20.77 | 47.91 | 0.00 |